Biomaneo

Dijon, France

In Vitro Diagnostics Clinical Diagnostics Laboratory Testing Diagnostics & Monitoring

Biomaneo designs and markets innovative medical analysis kits using mass spectrometry for detailed protein analysis. Their solutions target neonatal screening and pathology diagnosis within hospital laboratories. Operating on a B2B model, they serve healthcare professionals and corporate entities. Key offerings include NeoSickle for sickle cell disease and NeoHemog for hemoglobin variants. The company integrates bioinformatics to process data and assist in interpretation, aiming to automate biological screening, enhance efficiency, reduce mortality, and lower analysis costs. With CE IVDR and ISO 13485 certifications, Biomaneo bridges bioconcepts with clinical applications through precise and traceable diagnostic tools.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Biomaneo on @MedStartr Today #NeonatalIntensiveCare #PrematurityNeonatalConditions #Diagnostics #Laboratory #InVitroDiagnostics #ClinicalDiagnostics #LaboratoryTesting #DiagnosticsScreeningMonitoring #MedMo #MedStartrVentures

https://www.medstartr.ai/s/QAyeDUo0Fv8

Get Involved in Biomaneo

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2016
Website: biomaneo.fr/

Disease Areas

Neonatal Intensive Care Prematurity & Neonatal Conditions Diagnostics Laboratory

Technologies

In Vitro DiagnosticsMass SpectrometryProteomicsMolecular Diagnostics

🌐Website

What do you think of Biomaneo?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.